Seeking Alpha

OMTH
  Omthera Pharmaceuticals - NASDAQ

9/16/2014, 9:30 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
OMTH vs. ETF Alternatives
Company Description
We are an emerging specialty pharmaceutical company focused on the development and commercialization of new therapies for abnormalities in blood lipids, referred to as dyslipidemia, and the treatment of cardiovascular disease. Epanova, currently our sole product candidate, is a late-stage,... More
Sector: Healthcare
Industry: Drugs - Generic
Country: United States